Sheppard Pratt Health System

Recent papers from Sheppard Pratt Health System

1. Durability of Implanted Cervical Vagus Nerve Stimulation in Treatment-resistant Major Depression: Summary of Findings and Potential Mechanisms of ActionCurrent Addiction Reports · 2026
2. A Digital Therapeutic Intervention for Negative Symptoms of SchizophreniaJAMA Network Open · 2026
3. The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future DirectionsAmerican Journal of Psychiatry · 2026
4. Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian LensPsychodynamic Psychiatry · 2026
5. Beyond the Hospital: Understanding Psychosocial Support Uptake for Adolescents and Young Adults With Cancer in Community-Based and Nonprofit ProgramsCancer Control · 2026
6. Efficacy, Acceptability, and Feasibility of StayQuit for Sustaining Smoking Abstinence After Psychiatric Hospitalization: A Pilot StudyJournal of patient-centered research and reviews · 2026
7. The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensusThe British Journal of Psychiatry · 2026
8. The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensusThe British Journal of Psychiatry · 2026
9. The association between psychotropic medications and cognitive functioning in bipolar disorderInternational Journal of Bipolar Disorders · 2026
10. Recommendations for the Deprescribing of Psychotropic MedicationsJAMA Network Open · 2026
11. Risk Factors for Natural Cause Mortality in Bipolar DisorderBipolar Disorders · 2026
12. Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trialJournal of Affective Disorders · 2026
13. Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial reportThe International Journal of Neuropsychopharmacology · 2025
14. Levels of matrix metalloproteinase 9 (MMP-9) are elevated in persons with major depressive disorder who have had a recent suicide attemptBrain Behavior & Immunity - Health · 2025
15. Near‐Term Risk for Psychosis and Non‐Psychosis‐Related Suicide: A Retrospective Examination of the Last 30 Days of LifeSuicide and Life-Threatening Behavior · 2025
16. Near‐Term Risk for Psychosis and Non‐Psychosis‐Related Suicide: A Retrospective Examination of the Last 30 Days of LifeSuicide and Life-Threatening Behavior · 2025
17. Risk factors for unnatural mortality in persons with serious mental illnessScientific Reports · 2025
18. The trajectory of symptom change over the course of transcranial magnetic stimulation for major depressive disorderBrain stimulation · 2025
19. Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled TrialJMIR Research Protocols · 2025
20. A commercial scale evaluation of the effects of post-weaning management system of dairy × beef hybrid steers compared to native beef steers on performance, carcass characteristics, and net returnsTranslational Animal Science · 2025